Bionik Laboratories Corp.

Symbol: BNKL




Market price today

  • -0.1900

    P/E Ratio

  • 0.0015

    PEG Ratio

  • 35.06M

    MRK Cap

  • 0.00%

    DIV Yield

Bionik Laboratories Corp. (BNKL) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Medical Care Facilities
CEO:Mr. Richard Paul Russo Jr., CPA
Full-time employees:12
Address:80 Coolidge Hill Road

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

General Outlook

In simple terms, Bionik Laboratories Corp. has 12 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.526% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -2.209%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -2.350%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -1.092% return, is a testament to Bionik Laboratories Corp.'s adeptness in optimizing resource deployment. Bionik Laboratories Corp.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 6.719%. Furthermore, the proficiency of Bionik Laboratories Corp. in capital utilization is underscored by a remarkable -3.278% return on capital employed.

Stock Prices

Bionik Laboratories Corp.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.1, while its low point bottomed out at $0.1. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Bionik Laboratories Corp.'s stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2023?

There are stock number shares outstanding of Bionik Laboratories Corp. (BNKL) on the PNK in 2023.

What is P/E ratio of enterprise in 2023?

The current P/E ratio of enterprise is -0.190 in 2023.

What is the ticker symbol of Bionik Laboratories Corp. stock?

The ticker symbol of Bionik Laboratories Corp. stock is BNKL.

What is company IPO date?

IPO date of Bionik Laboratories Corp. is 2015-03-05.

What is company current share price?

Current share price is 0.100 USD.

What is stock market cap today?

The market cap of stock today is 35061900.000.

What is PEG ratio in 2023?

The current 0.002 is 0.002 in 2023.

What is the number of employees in 2023?

In 2023 the company has 12.